Table 2 Surgery related details and clinical outcome in zone2/3 and zone4 APA patients (n (%))
Variable | Zone2/3 APA (n = 12) | Zone4 APA (n = 25) | Total (%) (n = 37) | p |
|---|---|---|---|---|
Surgery opportunity | Â | Â | Â | 0.406 |
 Emergent TEVAR | 3a | 4 | 7 (18.9) |  |
 Elective TEVAR | 9b | 21 | 30 (81.1) |  |
Stent type | Â | Â | Â | Â |
 Ankura, Lifetech | 5 | 14 | 19 (51.4) |  |
 Valiant, Medtronic | 3 | 6 | 9 (24.3) |  |
 Hercules, Microport | 3 | 3 | 6 (16.2) |  |
 Zenith TX2, Cook | 1 | 1 | 2 (5.4) |  |
 Relay, Bolton | 0 | 1 | 1 (2.7) |  |
Early mortality | 3 | 0 | 3 (8.1) | 0.028 |
Early morbidity | Â | Â | Â | 0.642 |
 Acute arterial embolism of lower extremity | 1 | 0 | 1 (2.7) |  |
 Type II endoleak | 0 | 1 | 1 (2.7) |  |
Secondary intervention | 0 | 1c | 1 (2.7) | 0.676 |
Midterm survival | Â | Â | Â | 0.013d |
 3 months | 65.6 ± 14.0 | 100.0 ± 0.0 | 88.8 ± 5.3 |  |
 6 months | 56.3 ± 14.8 | 100.0 ± 0.0 | 85.8 ± 5.9 |  |
 1 year | 56.3 ± 14.8 | 85.0 ± 8.0 | 75.9 ± 7.5 |  |
 3 years | 56.3 ± 14.8 | 85.0 ± 8.0 | 75.9 ± 7.5 |  |
 5 years | 56.3 ± 14.8 | 72.9 ± 13.2 | 68.3 ± 9.9 |  |